SEC Company Response from Summit Therapeutics Inc. (SMMT) (CIK 0001599298) (SMMT) — May 24, 2018
Summit Therapeutics Inc. (SMMT) (CIK 0001599298)
Date: May 24, 2018 · CIK: 0001599298 · Accession: 0001193125-18-173504
AI Filing Summary & Sentiment
File numbers found in text: 333-224938
Letter
Acceleration Request
Summit Therapeutics plc
136a Eastern Avenue
Milton Park, Abingdon
Oxfordshire OX14 4SB
United Kingdom
May 24, 2018
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C.
Re: Summit Therapeutics plc
Registration Statement on Form F-3
File No. 333-224938
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Summit Therapeutics plc (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form F-3 (File No. 333-224938) (the “Registration Statement”), so that it may become effective at 4:00 p.m. Eastern time on May 29, 2018, or as soon thereafter as practicable.
Very truly yours,
SUMMIT THERAPEUTICS PLC
Show Raw Text
CORRESP 1 filename1.htm Acceleration Request Summit Therapeutics plc 136a Eastern Avenue Milton Park, Abingdon Oxfordshire OX14 4SB United Kingdom May 24, 2018 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Summit Therapeutics plc Registration Statement on Form F-3 File No. 333-224938 Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Summit Therapeutics plc (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form F-3 (File No. 333-224938) (the “Registration Statement”), so that it may become effective at 4:00 p.m. Eastern time on May 29, 2018, or as soon thereafter as practicable. Very truly yours, SUMMIT THERAPEUTICS PLC By: /s/ Erik Ostrowski Name: Erik Ostrowski Title: Chief Financial Officer